| UniProt ID | SYK_HUMAN | |
|---|---|---|
| UniProt AC | Q15046 | |
| Protein Name | Lysine--tRNA ligase | |
| Gene Name | KARS | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 597 | |
| Subcellular Localization |
Isoform Cytoplasmic: Cytoplasm, cytosol . Cytoplasm . Nucleus . Cell membrane Peripheral membrane protein . Secreted . Secretion is induced by TNF-alpha (PubMed:15851690). Cytosolic in quiescent mast cells. Translocates into the nucleus in response |
|
| Protein Description | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. [PubMed: 9278442] | |
| Protein Sequence | MAAVQAAEVKVDGSEPKLSKNELKRRLKAEKKVAEKEAKQKELSEKQLSQATAAATNHTTDNGVGPEEESVDPNQYYKIRSQAIHQLKVNGEDPYPHKFHVDISLTDFIQKYSHLQPGDHLTDITLKVAGRIHAKRASGGKLIFYDLRGEGVKLQVMANSRNYKSEEEFIHINNKLRRGDIIGVQGNPGKTKKGELSIIPYEITLLSPCLHMLPHLHFGLKDKETRYRQRYLDLILNDFVRQKFIIRSKIITYIRSFLDELGFLEIETPMMNIIPGGAVAKPFITYHNELDMNLYMRIAPELYHKMLVVGGIDRVYEIGRQFRNEGIDLTHNPEFTTCEFYMAYADYHDLMEITEKMVSGMVKHITGSYKVTYHPDGPEGQAYDVDFTPPFRRINMVEELEKALGMKLPETNLFETEETRKILDDICVAKAVECPPPRTTARLLDKLVGEFLEVTCINPTFICDHPQIMSPLAKWHRSKEGLTERFELFVMKKEICNAYTELNDPMRQRQLFEEQAKAKAAGDDEAMFIDENFCTALEYGLPPTAGWGMGIDRVAMFLTDSNNIKEVLLFPAMKPEDKKENVATTDTLESTTVGTSV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAVQAAEV ------CCCCEEEEE | 19.15 | 22223895 | |
| 3 (in isoform 2) | Phosphorylation | - | 7.83 | 25072903 | |
| 8 | Ubiquitination | MAAVQAAEVKVDGSE CCCCEEEEEECCCCC | 45.98 | 24816145 | |
| 10 | 2-Hydroxyisobutyrylation | AVQAAEVKVDGSEPK CCEEEEEECCCCCCC | 26.55 | - | |
| 10 | Ubiquitination | AVQAAEVKVDGSEPK CCEEEEEECCCCCCC | 26.55 | - | |
| 14 | Phosphorylation | AEVKVDGSEPKLSKN EEEECCCCCCCCCHH | 46.38 | 24850871 | |
| 17 | Ubiquitination | KVDGSEPKLSKNELK ECCCCCCCCCHHHHH | 62.43 | 24816145 | |
| 17 (in isoform 2) | Phosphorylation | - | 62.43 | 21406692 | |
| 18 (in isoform 2) | Phosphorylation | - | 14.95 | 21406692 | |
| 20 | 2-Hydroxyisobutyrylation | GSEPKLSKNELKRRL CCCCCCCHHHHHHHH | 65.95 | - | |
| 31 | Acetylation | KRRLKAEKKVAEKEA HHHHHHHHHHHHHHH | 58.36 | 30589629 | |
| 34 | Ubiquitination | LKAEKKVAEKEAKQK HHHHHHHHHHHHHHH | 30.90 | 27667366 | |
| 44 | Phosphorylation | EAKQKELSEKQLSQA HHHHHHHCHHHHHHH | 43.79 | 24719451 | |
| 49 | Phosphorylation | ELSEKQLSQATAAAT HHCHHHHHHHHHHHH | 18.44 | 28348404 | |
| 52 | Phosphorylation | EKQLSQATAAATNHT HHHHHHHHHHHHCCC | 14.80 | 28348404 | |
| 56 | Phosphorylation | SQATAAATNHTTDNG HHHHHHHHCCCCCCC | 23.86 | 28348404 | |
| 59 | Phosphorylation | TAAATNHTTDNGVGP HHHHHCCCCCCCCCC | 37.60 | 28348404 | |
| 60 | Phosphorylation | AAATNHTTDNGVGPE HHHHCCCCCCCCCCC | 21.66 | 28348404 | |
| 78 | Acetylation | VDPNQYYKIRSQAIH CCHHHHHEEHHHHHE | 27.06 | 26051181 | |
| 78 | Ubiquitination | VDPNQYYKIRSQAIH CCHHHHHEEHHHHHE | 27.06 | 22817900 | |
| 78 (in isoform 1) | Ubiquitination | - | 27.06 | 21890473 | |
| 81 | Phosphorylation | NQYYKIRSQAIHQLK HHHHEEHHHHHEEEE | 27.69 | 28857561 | |
| 88 | Acetylation | SQAIHQLKVNGEDPY HHHHEEEEECCCCCC | 27.38 | 19608861 | |
| 88 | Methylation | SQAIHQLKVNGEDPY HHHHEEEEECCCCCC | 27.38 | 22640393 | |
| 95 | Phosphorylation | KVNGEDPYPHKFHVD EECCCCCCCCCCEEE | 30.23 | 28152594 | |
| 106 | Ubiquitination | FHVDISLTDFIQKYS CEEEEEHHHHHHHHC | 23.29 | 21890473 | |
| 106 (in isoform 2) | Ubiquitination | - | 23.29 | 21890473 | |
| 111 | Acetylation | SLTDFIQKYSHLQPG EHHHHHHHHCCCCCC | 43.85 | 25038526 | |
| 112 | Phosphorylation | LTDFIQKYSHLQPGD HHHHHHHHCCCCCCC | 5.73 | 28152594 | |
| 113 | Phosphorylation | TDFIQKYSHLQPGDH HHHHHHHCCCCCCCC | 25.42 | 28152594 | |
| 116 | Acetylation | IQKYSHLQPGDHLTD HHHHCCCCCCCCHHH | 34.21 | 19608861 | |
| 127 | 2-Hydroxyisobutyrylation | HLTDITLKVAGRIHA CHHHHHHEECCEEEE | 22.76 | - | |
| 127 | Acetylation | HLTDITLKVAGRIHA CHHHHHHEECCEEEE | 22.76 | 25953088 | |
| 127 | Ubiquitination | HLTDITLKVAGRIHA CHHHHHHEECCEEEE | 22.76 | 32015554 | |
| 135 | Ubiquitination | VAGRIHAKRASGGKL ECCEEEEEECCCCEE | 34.04 | 23000965 | |
| 141 | 2-Hydroxyisobutyrylation | AKRASGGKLIFYDLR EEECCCCEEEEEECC | 41.77 | - | |
| 141 | Acetylation | AKRASGGKLIFYDLR EEECCCCEEEEEECC | 41.77 | 19608861 | |
| 141 | Malonylation | AKRASGGKLIFYDLR EEECCCCEEEEEECC | 41.77 | 26320211 | |
| 141 | Succinylation | AKRASGGKLIFYDLR EEECCCCEEEEEECC | 41.77 | 27452117 | |
| 141 | Ubiquitination | AKRASGGKLIFYDLR EEECCCCEEEEEECC | 41.77 | 23000965 | |
| 148 | Methylation | KLIFYDLRGEGVKLQ EEEEEECCCCCEEEE | 37.91 | 115480819 | |
| 149 | Ubiquitination | LIFYDLRGEGVKLQV EEEEECCCCCEEEEE | 43.22 | 23000965 | |
| 153 | Acetylation | DLRGEGVKLQVMANS ECCCCCEEEEEEECC | 44.02 | 25953088 | |
| 155 | Ubiquitination | RGEGVKLQVMANSRN CCCCEEEEEEECCCC | 19.75 | 32015554 | |
| 163 | Ubiquitination | VMANSRNYKSEEEFI EEECCCCCCCHHHEE | 18.12 | 23000965 | |
| 164 | Acetylation | MANSRNYKSEEEFIH EECCCCCCCHHHEEE | 55.74 | 25038526 | |
| 164 | Ubiquitination | MANSRNYKSEEEFIH EECCCCCCCHHHEEE | 55.74 | 24816145 | |
| 169 | Acetylation | NYKSEEEFIHINNKL CCCCHHHEEECCCCC | 5.80 | 19608861 | |
| 169 | Ubiquitination | NYKSEEEFIHINNKL CCCCHHHEEECCCCC | 5.80 | 23000965 | |
| 169 (in isoform 2) | Malonylation | - | 5.80 | 26320211 | |
| 169 (in isoform 2) | Ubiquitination | - | 5.80 | - | |
| 175 | 2-Hydroxyisobutyrylation | EFIHINNKLRRGDII HEEECCCCCCCCCEE | 38.59 | - | |
| 175 | Acetylation | EFIHINNKLRRGDII HEEECCCCCCCCCEE | 38.59 | 23954790 | |
| 175 | Ubiquitination | EFIHINNKLRRGDII HEEECCCCCCCCCEE | 38.59 | 29967540 | |
| 190 | Ubiquitination | GVQGNPGKTKKGELS EECCCCCCCCCCEEE | 59.43 | 27667366 | |
| 192 | Ubiquitination | QGNPGKTKKGELSII CCCCCCCCCCEEEEC | 63.37 | 24816145 | |
| 203 | Ubiquitination | LSIIPYEITLLSPCL EEECCEEEHHHHHHH | 2.44 | 29967540 | |
| 207 | Phosphorylation | PYEITLLSPCLHMLP CEEEHHHHHHHHHHH | 19.38 | 19524539 | |
| 207 | Ubiquitination | PYEITLLSPCLHMLP CEEEHHHHHHHHHHH | 19.38 | 21890473 | |
| 218 | Ubiquitination | HMLPHLHFGLKDKET HHHHHHCCCCCCHHH | 18.04 | 27667366 | |
| 249 | 2-Hydroxyisobutyrylation | QKFIIRSKIITYIRS HHHHHHHHHHHHHHH | 28.42 | - | |
| 249 | Ubiquitination | QKFIIRSKIITYIRS HHHHHHHHHHHHHHH | 28.42 | - | |
| 251 | Ubiquitination | FIIRSKIITYIRSFL HHHHHHHHHHHHHHH | 2.48 | 33845483 | |
| 265 | Ubiquitination | LDELGFLEIETPMMN HHHHCCCEEECCCEE | 36.20 | 23000965 | |
| 274 | Ubiquitination | ETPMMNIIPGGAVAK ECCCEECCCCCCCCC | 1.89 | 21963094 | |
| 305 | Ubiquitination | IAPELYHKMLVVGGI HCHHHHHHHHHHCCC | 22.00 | 23000965 | |
| 305 (in isoform 1) | Ubiquitination | - | 22.00 | 21890473 | |
| 314 | Methylation | LVVGGIDRVYEIGRQ HHHCCCHHHHHHHHH | 30.88 | 115480827 | |
| 333 | Ubiquitination | GIDLTHNPEFTTCEF CCCCCCCCCCCCEEE | 30.40 | 23000965 | |
| 333 (in isoform 2) | Ubiquitination | - | 30.40 | 21890473 | |
| 336 | Ubiquitination | LTHNPEFTTCEFYMA CCCCCCCCCEEEEEE | 28.95 | 21890473 | |
| 361 | Ubiquitination | TEKMVSGMVKHITGS HHHHHHHHHHHHCCE | 2.56 | 33845483 | |
| 363 | Acetylation | KMVSGMVKHITGSYK HHHHHHHHHHCCEEE | 22.01 | 25953088 | |
| 363 | Ubiquitination | KMVSGMVKHITGSYK HHHHHHHHHHCCEEE | 22.01 | 22817900 | |
| 363 (in isoform 1) | Ubiquitination | - | 22.01 | 21890473 | |
| 366 | Phosphorylation | SGMVKHITGSYKVTY HHHHHHHCCEEEEEE | 21.57 | 22210691 | |
| 368 | Phosphorylation | MVKHITGSYKVTYHP HHHHHCCEEEEEECC | 17.09 | 22210691 | |
| 391 | Ubiquitination | DVDFTPPFRRINMVE ECCCCCCCCCCCHHH | 9.62 | 21890473 | |
| 391 (in isoform 2) | Ubiquitination | - | 9.62 | 21890473 | |
| 396 | Sulfoxidation | PPFRRINMVEELEKA CCCCCCCHHHHHHHH | 3.60 | 21406390 | |
| 402 | Acetylation | NMVEELEKALGMKLP CHHHHHHHHHCCCCC | 62.63 | 19608861 | |
| 402 | Ubiquitination | NMVEELEKALGMKLP CHHHHHHHHHCCCCC | 62.63 | 29967540 | |
| 407 | Ubiquitination | LEKALGMKLPETNLF HHHHHCCCCCCCCCC | 60.12 | 33845483 | |
| 421 | 2-Hydroxyisobutyrylation | FETEETRKILDDICV CCCHHHHHHHHHHHH | 55.85 | - | |
| 421 | Ubiquitination | FETEETRKILDDICV CCCHHHHHHHHHHHH | 55.85 | 23000965 | |
| 421 (in isoform 1) | Ubiquitination | - | 55.85 | 21890473 | |
| 422 | Ubiquitination | ETEETRKILDDICVA CCHHHHHHHHHHHHH | 4.61 | 33845483 | |
| 423 | Ubiquitination | TEETRKILDDICVAK CHHHHHHHHHHHHHH | 5.62 | 33845483 | |
| 427 | Glutathionylation | RKILDDICVAKAVEC HHHHHHHHHHHHCCC | 2.91 | 22555962 | |
| 430 | 2-Hydroxyisobutyrylation | LDDICVAKAVECPPP HHHHHHHHHCCCCCC | 32.35 | - | |
| 430 | Acetylation | LDDICVAKAVECPPP HHHHHHHHHCCCCCC | 32.35 | 26051181 | |
| 430 | Ubiquitination | LDDICVAKAVECPPP HHHHHHHHHCCCCCC | 32.35 | 21963094 | |
| 435 | Ubiquitination | VAKAVECPPPRTTAR HHHHCCCCCCHHHHH | 28.55 | 32015554 | |
| 449 | Ubiquitination | RLLDKLVGEFLEVTC HHHHHHHHHHHEEEE | 30.30 | 23000965 | |
| 449 (in isoform 2) | Ubiquitination | - | 30.30 | 21890473 | |
| 458 | Ubiquitination | FLEVTCINPTFICDH HHEEEECCCEEECCC | 31.54 | 21963094 | |
| 460 | Phosphorylation | EVTCINPTFICDHPQ EEEECCCEEECCCHH | 22.57 | 25850435 | |
| 470 | Phosphorylation | CDHPQIMSPLAKWHR CCCHHHHCHHHHHHH | 20.56 | 25850435 | |
| 492 | 2-Hydroxyisobutyrylation | RFELFVMKKEICNAY HHHEHHHHHHHHHHH | 41.79 | - | |
| 492 | Acetylation | RFELFVMKKEICNAY HHHEHHHHHHHHHHH | 41.79 | 25953088 | |
| 492 | Ubiquitination | RFELFVMKKEICNAY HHHEHHHHHHHHHHH | 41.79 | 21890473 | |
| 492 (in isoform 1) | Ubiquitination | - | 41.79 | 21890473 | |
| 493 | 2-Hydroxyisobutyrylation | FELFVMKKEICNAYT HHEHHHHHHHHHHHH | 33.93 | - | |
| 493 | Acetylation | FELFVMKKEICNAYT HHEHHHHHHHHHHHH | 33.93 | 26051181 | |
| 493 | Ubiquitination | FELFVMKKEICNAYT HHEHHHHHHHHHHHH | 33.93 | 29967540 | |
| 496 | Glutathionylation | FVMKKEICNAYTELN HHHHHHHHHHHHHHC | 2.21 | 22555962 | |
| 506 | Sulfoxidation | YTELNDPMRQRQLFE HHHHCCHHHHHHHHH | 6.77 | 21406390 | |
| 517 | Acetylation | QLFEEQAKAKAAGDD HHHHHHHHHHHCCCC | 50.55 | 25953088 | |
| 517 | Ubiquitination | QLFEEQAKAKAAGDD HHHHHHHHHHHCCCC | 50.55 | 33845483 | |
| 520 | Ubiquitination | EEQAKAKAAGDDEAM HHHHHHHHCCCCCCE | 22.87 | 21890473 | |
| 520 (in isoform 2) | Ubiquitination | - | 22.87 | 21890473 | |
| 521 | Ubiquitination | EQAKAKAAGDDEAMF HHHHHHHCCCCCCEE | 22.65 | 29967540 | |
| 545 | Ubiquitination | EYGLPPTAGWGMGID HHCCCCCCCCCCCCC | 19.95 | 33845483 | |
| 556 | Sulfoxidation | MGIDRVAMFLTDSNN CCCCEEEEEEECCCC | 2.30 | 21406390 | |
| 561 | Phosphorylation | VAMFLTDSNNIKEVL EEEEEECCCCCEEEE | 26.92 | 21712546 | |
| 573 | Sulfoxidation | EVLLFPAMKPEDKKE EEEEEECCCCCCCCC | 8.29 | 21406390 | |
| 574 | 2-Hydroxyisobutyrylation | VLLFPAMKPEDKKEN EEEEECCCCCCCCCC | 47.57 | - | |
| 574 | Acetylation | VLLFPAMKPEDKKEN EEEEECCCCCCCCCC | 47.57 | 25038526 | |
| 578 | Ubiquitination | PAMKPEDKKENVATT ECCCCCCCCCCCCCC | 61.39 | 32015554 | |
| 579 | Ubiquitination | AMKPEDKKENVATTD CCCCCCCCCCCCCCC | 67.83 | 33845483 | |
| 584 | Phosphorylation | DKKENVATTDTLEST CCCCCCCCCCCCCCC | 22.41 | 30257219 | |
| 585 | Phosphorylation | KKENVATTDTLESTT CCCCCCCCCCCCCCC | 19.76 | 27251275 | |
| 587 | Phosphorylation | ENVATTDTLESTTVG CCCCCCCCCCCCCCC | 30.27 | 29970186 | |
| 590 | Phosphorylation | ATTDTLESTTVGTSV CCCCCCCCCCCCCCC | 32.27 | 29514088 | |
| 591 | Phosphorylation | TTDTLESTTVGTSV- CCCCCCCCCCCCCC- | 19.00 | 30266825 | |
| 592 | Phosphorylation | TDTLESTTVGTSV-- CCCCCCCCCCCCC-- | 26.64 | 29514088 | |
| 595 | Phosphorylation | LESTTVGTSV----- CCCCCCCCCC----- | 23.21 | 30266825 | |
| 596 | Phosphorylation | ESTTVGTSV------ CCCCCCCCC------ | 21.65 | 30266825 | |
| 606 | Ubiquitination | ---------------- ---------------- | 32015554 | ||
| 607 | Ubiquitination | ----------------- ----------------- | 33845483 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYK_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYK_HUMAN !! | ||||||
| Kegg Disease | |
|---|---|
| H00264 | Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atroph |
| OMIM Disease | |
| 613641 | Charcot-Marie-Tooth disease, recessive, intermediate type, B (CMTRIB) |
| 613916 | Deafness, autosomal recessive, 89 (DFNB89) |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00123 | L-Lysine |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM CYTOPLASMIC),PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-596, AND MASSSPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-88; LYS-141 AND LYS-402, ANDMASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2 (ISOFORM CYTOPLASMIC),PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-596, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-587, AND MASSSPECTROMETRY. | |